{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:34:08Z","timestamp":1776371648445,"version":"3.51.2"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["EU COST Action IS1402 \u201cAgeism - a multi-national, interdisciplinary perspective\u201d (2015\u20132018)"],"award-info":[{"award-number":["EU COST Action IS1402 \u201cAgeism - a multi-national, interdisciplinary perspective\u201d (2015\u20132018)"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["EUROAGEISM Horizon 2020 project EC no. 764632 MSCA-ITN (2017\u20132021)"],"award-info":[{"award-number":["EUROAGEISM Horizon 2020 project EC no. 764632 MSCA-ITN (2017\u20132021)"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00228-018-2603-5","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T09:54:10Z","timestamp":1546595650000},"page":"451-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies)"],"prefix":"10.1007","volume":"75","author":[{"name":"for the EUROAGEISM H2020 project and WG1b group \u201cHealthy clinical strategies for healthy aging\u201d of the EU COST Action IS 1402","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-9690","authenticated-orcid":false,"given":"Daniela","family":"Fialov\u00e1","sequence":"first","affiliation":[]},{"given":"Blanca","family":"Laffon","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Marinkovi\u0107","sequence":"additional","affiliation":[]},{"given":"Ljiljana","family":"Tasi\u0107","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Doro","sequence":"additional","affiliation":[]},{"given":"Gy\u04e7ngyver","family":"S\u03ccos","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Mota","sequence":"additional","affiliation":[]},{"given":"Soner","family":"Dogan","sequence":"additional","affiliation":[]},{"given":"Jovana","family":"Brki\u0107","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Vanessa","family":"Valdiglesias","sequence":"additional","affiliation":[]},{"given":"Solange","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"2603_CR1","unstructured":"World Health Organization (WHO) (2014) Ageing and life-course: facts about ageing. Available online at: \n                    http:\/\/www.who.int\/ageing\/about\/facts\/en\n                    \n                  . Accessed 10 Jul 2018"},{"issue":"6","key":"2603_CR2","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1532-5415.2009.02266.x","volume":"57","author":"A Corsonello","year":"2009","unstructured":"Corsonello A, Pedone C, Lattanzio F, Lucchetti M, Garasto S, Di Muzio M, Giunta S, Onder G, Di Iorio A, Volpato S, Corica F, Mussi C, Antonelli Incalzi R; Pharmacosur Veillance in the Elderly Care Study Group (2009) Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 57(6):1007\u20131014. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02266.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2603_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40266-016-0361-6","volume":"33","author":"D Fialov\u00e1","year":"2016","unstructured":"Fialov\u00e1 D, Desplenter F (2016) Aging of the population, clinical pharmacy services, and interdisciplinary cooperation in the optimization of pharmacotherapy in older patients. Drugs Aging 33(3):163\u2013167. \n                    https:\/\/doi.org\/10.1007\/s40266-016-0361-6","journal-title":"Drugs Aging"},{"issue":"6","key":"2603_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2165\/11631720-000000000-00000","volume":"29","author":"A Spinewine","year":"2012","unstructured":"Spinewine A, Fialov\u00e1 D, Byrne S (2012) The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 29(6):495\u2013510. \n                    https:\/\/doi.org\/10.2165\/11631720-000000000-00000","journal-title":"Drugs Aging"},{"issue":"4","key":"2603_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1586\/17512433.2014.922864","volume":"7","author":"P Crome","year":"2014","unstructured":"Crome P, Cherubini A, Oristrell J (2014) The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond. Expert Rev Clin Pharmacol 7(4):457\u2013468. \n                    https:\/\/doi.org\/10.1586\/17512433.2014.922864","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"2603_CR6","first-page":"54","volume":"55","author":"JS Cohen","year":"2000","unstructured":"Cohen JS (2000) Avoiding adverse reactions. Effective lower-dose drug therapies for older patients. Geriatrics 55(2):54\u201356, 59\u201360, 63\u201364","journal-title":"Geriatrics"},{"issue":"1","key":"2603_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/geront\/gnt015","volume":"54","author":"WA Achenbaum","year":"2014","unstructured":"Achenbaum WA (2014) Robert N. Butler, MD (January 21, 1927\u2013July 4, 2010): visionary leader. Gerontologist 54(1):6\u201312. \n                    https:\/\/doi.org\/10.1093\/geront\/gnt015","journal-title":"Gerontologist"},{"key":"2603_CR8","doi-asserted-by":"publisher","unstructured":"Fialov\u00e1 D, Kummer I, Dr\u017eai\u0107 M, Leppee M (2018) Ageism in medication use in older patients. In: Ayalon L, Tesch-R\u00f6mer C (eds) Contemporary perspectives on ageism. Springer International Publishing. \n                    https:\/\/doi.org\/10.1007\/978-3-319-73820-8","DOI":"10.1007\/978-3-319-73820-8"},{"key":"2603_CR9","unstructured":"EU H2020 \u201cEUROAGEISM\u201d project (2017\u20132021). Faculty of Pharmacy in Hradec Kralove Charles University - Science Portal. Home page at: \n                    https:\/\/portal.faf.cuni.cz\/Research-Overview\/Euroageism-project\/?lang=cs-CZ\n                    \n                  . Accessed 7 Jul 2018"},{"key":"2603_CR10","unstructured":"COST Action IS1402 on Ageism. Home page at: \n                    http:\/\/notoageism.com\n                    \n                  . Accessed 10 Jul 2018"},{"key":"2603_CR11","volume-title":"Therapeutics in the elderly","author":"W Simonson","year":"2001","unstructured":"Simonson W (2001) Introduction to the aging process. In: Delafuente JC, Steward RB (eds) Therapeutics in the elderly, 3rd edn. Harvey Whitney Books Company, Cincinnati, Ohio, 842 pp","edition":"3"},{"issue":"12","key":"2603_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40266-015-0318-1","volume":"32","author":"JL Tan","year":"2015","unstructured":"Tan JL, Eastment JG, Poudel A, Hubbard RE (2015) Age-related changes in hepatic function: an update on implications for drug therapy. Drugs Aging 32(12):999\u20131008. \n                    https:\/\/doi.org\/10.1007\/s40266-015-0318-1","journal-title":"Drugs Aging"},{"issue":"8","key":"2603_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4140\/TCP.n.2004.736","volume":"19","author":"D Tobias","year":"2004","unstructured":"Tobias D (2004) Age-related changes in pharmacokinetics and pharmacodynamics: a review. Consult Pharm 19(8):736\u2013739","journal-title":"Consult Pharm"},{"issue":"6","key":"2603_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2125.2009.03419.x","volume":"67","author":"D Fialov\u00e1","year":"2009","unstructured":"Fialov\u00e1 D, Onder G (2009) Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 67(6):641\u2013645. \n                    https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03419.x","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"2603_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/jgs.13067","volume":"62","author":"E Beers","year":"2014","unstructured":"Beers E, Moerkerken DC, Leufkens HG, Egberts TC, Jansen PA (2014) Participation of older people in preauthorization trials of recently approved medicines. J Am Geriatr Soc 62(10):1883\u20131890. \n                    https:\/\/doi.org\/10.1111\/jgs.13067","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2603_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033559","volume":"7","author":"C Konrat","year":"2012","unstructured":"Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P (2012) Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One 7(3):e33559. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0033559","journal-title":"PLoS One"},{"issue":"6","key":"2603_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ageing\/afr115","volume":"40","author":"ME McMurdo","year":"2011","unstructured":"McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C, Jackson S, Gladman J, O\u2019Mahony S, Ali K, Dickinson E, Edison P, Dyer C; Age and Ageing Specialty Group, NIHR, Comprehensive Clinical Research Network (2011) Improving recruitment of older people to research through good practice. Age Ageing 40(6):659\u2013665. \n                    https:\/\/doi.org\/10.1093\/ageing\/afr115","journal-title":"Age Ageing"},{"issue":"5","key":"2603_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.parkreldis.2012.03.003","volume":"18","author":"PR Fitzsimmons","year":"2012","unstructured":"Fitzsimmons PR, Blayney S, Mina-Corkill S, Scott GO (2012) Older participants are frequently excluded from Parkinson\u2019s disease research. Parkinsonism Relat Disord 18(5):585\u2013589. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.003","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2603_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/107327481402100305","volume":"21","author":"AC Denson","year":"2014","unstructured":"Denson AC, Mahipal A (2014) Participation of the elderly population in clinical trials: barriers and solutions. Cancer Control 21(3):209\u2013214. \n                    https:\/\/doi.org\/10.1177\/107327481402100305","journal-title":"Cancer Control"},{"issue":"5","key":"2603_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/jgs.12215","volume":"61","author":"AJ Cruz-Jentoft","year":"2013","unstructured":"Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasqu\u00edn B, S\u00e1nchez-Castellano C, S\u00e1nchez-Garc\u00eda E (2013) Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc 61(5):734\u2013738. \n                    https:\/\/doi.org\/10.1111\/jgs.12215","journal-title":"J Am Geriatr Soc"},{"key":"2603_CR21","unstructured":"European Medicines Agency (2010) ICH topic E7. Studies in support of special populations: geriatrics questions and answers. Available online at: \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/ich-e-7-studies-support-special-populations-geriatrics-questions-answers-step-5_en.pdf\n                    \n                  . Accessed 2 Jul 2018"},{"key":"2603_CR22","doi-asserted-by":"publisher","first-page":"e4040","DOI":"10.1136\/bmj.e4040","volume":"344","author":"ME McMurdo","year":"2012","unstructured":"McMurdo ME (2012) Older people in clinical trials. No more arbitrary upper age limits for clinical research. BMJ 344:e4040. \n                    https:\/\/doi.org\/10.1136\/bmj.e4040","journal-title":"BMJ"},{"key":"2603_CR23","unstructured":"National Institute on Aging (NIA) (2015) Clinical trials. Recruiting older adults into research (ROAR) toolkit. Home page at: \n                    https:\/\/www.nia.nih.gov\/health\/recruiting-older-adults-research-roar-toolkit\n                    \n                  . Accessed 2 Jul 2018"},{"issue":"4","key":"2603_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1532-5415.2004.52174.x","volume":"52","author":"L Ferrucci","year":"2004","unstructured":"Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD; Interventions on Frailty Working Group (2004) Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 52(4):625\u2013634. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52174.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2603_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00002512-200724030-00002","volume":"24","author":"MD Witham","year":"2007","unstructured":"Witham MD, McMurdo ME (2007) How to get older people included in clinical studies. Drugs Aging 24(3):187\u2013196. \n                    https:\/\/doi.org\/10.2165\/00002512-200724030-00002","journal-title":"Drugs Aging"},{"key":"2603_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.arr.2016.02.004","volume":"27","author":"B Spiegeleer De","year":"2016","unstructured":"De Spiegeleer B, Wynendaele E, Bracke N, Veryser L, Taevernier L, Degroote A, Stalmans S (2016) Regulatory development of geriatric medicines: to GIP or not to GIP? Ageing Res Rev 27:23\u201336. \n                    https:\/\/doi.org\/10.1016\/j.arr.2016.02.004","journal-title":"Ageing Res Rev"},{"key":"2603_CR27","doi-asserted-by":"publisher","first-page":"D2","DOI":"10.1093\/eurheartj\/suv035","volume":"17","author":"AT Cohen","year":"2015","unstructured":"Cohen AT, Goto S, Schreiber K, Torp-Pedersen C (2015) Why do we need observational studies of everyday patients in the real-life setting? Eur Heart J Suppl 17:D2\u2013D8. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/suv035","journal-title":"Eur Heart J Suppl"},{"key":"2603_CR28","doi-asserted-by":"publisher","unstructured":"Poscia A, Collamati A, Milovanovic S, Vetrano DL, Liotta G, Petitti T, Di Pietro ML, Magnavita N, Ricciardi W, Cherubini A, Onder G (2017) Methodological issues in the observational studies conducted in older population: a narrative review. Epidemiol Biostat Public Health 14(2). \n                    https:\/\/doi.org\/10.2427\/12627","DOI":"10.2427\/12627"},{"issue":"10","key":"2603_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP; STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"issue":"5","key":"2603_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","volume":"10","author":"LP Garrison Jr","year":"2007","unstructured":"Garrison LP Jr, Neumann PJ, Erickson P, Marshall D, Mullins CD (2007) Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health 10(5):326\u2013335. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00186.x","journal-title":"Value Health"},{"issue":"3","key":"2603_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/bjc.2013.725","volume":"110","author":"CM Booth","year":"2014","unstructured":"Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110(3):551\u2013555. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.725","journal-title":"Br J Cancer"},{"issue":"11","key":"2603_CR32","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/jamainternmed.2016.5954","volume":"176","author":"DJ Graham","year":"2016","unstructured":"Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA (2016) Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med 176(11):1662\u20131671. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2016.5954","journal-title":"JAMA Intern Med"},{"issue":"11","key":"2603_CR33","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1080\/03007995.2017.1374935","volume":"33","author":"S Kohsaka","year":"2017","unstructured":"Kohsaka S, Murata T, Izumi N, Katada J, Wang F, Terayama Y (2017) Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data. Curr Med Res Opin 33(11):1955\u20131963. \n                    https:\/\/doi.org\/10.1080\/03007995.2017.1374935","journal-title":"Curr Med Res Opin"},{"key":"2603_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2018.05.019","volume":"53","author":"A Damiani","year":"2018","unstructured":"Damiani A, Onder G, Valentini V (2018) Large databases (big data) and evidence-based medicine. Eur J Intern Med 53:1\u20132. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2018.05.019","journal-title":"Eur J Intern Med"},{"issue":"7","key":"2603_CR35","doi-asserted-by":"publisher","first-page":"531.e11","DOI":"10.1016\/j.jamda.2014.04.005","volume":"15","author":"G Onder","year":"2014","unstructured":"Onder G, Vetrano DL, Cherubini A, Fini M, Mannucci PM, Marengoni A, Monaco A, Nobili A, Pecorelli S, Russo P, Vitale C, Bernabei R (2014) Prescription drug use among older adults in Italy: a country-wide perspective. J Am Med Dir Assoc 15(7):531.e11\u2013531.e15. \n                    https:\/\/doi.org\/10.1016\/j.jamda.2014.04.005","journal-title":"J Am Med Dir Assoc"},{"key":"2603_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-015-0026-z","volume":"15","author":"RE Hubbard","year":"2015","unstructured":"Hubbard RE, Peel NM, Samanta M, Gray LC, Fries BE, Mitnitski A, Rockwood K (2015) Derivation of a frailty index from the interRAI acute care instrument. BMC Geriatr 15:27. \n                    https:\/\/doi.org\/10.1186\/s12877-015-0026-z","journal-title":"BMC Geriatr"},{"key":"2603_CR37","unstructured":"Access data and reports. Seniors and ageing. Canadian Institute for Health Information (CIHI). Home page at: \n                    https:\/\/www.cihi.ca\/en\/access-data-reports\/results?f%5B0%5D=field_primary_theme%3A2054\n                    \n                  . Accessed 14 Nov 2018"},{"key":"2603_CR38","doi-asserted-by":"publisher","unstructured":"Fielding RA (2015) A summary of the biological basis of frailty. In: Proceedings of the 83rd Nestl\u00e9 Nutrition Institute Workshop, Barcelona, March 2014. \n                    https:\/\/doi.org\/10.1159\/000430966","DOI":"10.1159\/000430966"},{"issue":"5","key":"2603_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1365-2125.2012.04268.x","volume":"74","author":"CJ Keijsers","year":"2012","unstructured":"Keijsers CJ, van Hensbergen L, Jacobs L, Brouwers JR, de Wildt DJ, ten Cate OT, Jansen PA (2012) Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Br J Clin Pharmacol 74(5):762\u2013773. \n                    https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04268.x","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2603_CR40","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2603_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ageing\/afv166","volume":"45","author":"S Cullinan","year":"2016","unstructured":"Cullinan S, O\u2019Mahony D, O\u2019Sullivan D, Byrne S (2016) Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients. Age Ageing 45(1):115\u2013120. \n                    https:\/\/doi.org\/10.1093\/ageing\/afv166","journal-title":"Age Ageing"},{"issue":"6","key":"2603_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1532-5415.2005.53312.x","volume":"53","author":"K Rockwood","year":"2005","unstructured":"Rockwood K (2005) Frailty and its definition: a worthy challenge. J Am Geriatr Soc 53(6):1069\u20131070. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53312.x","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2603_CR43","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/j.1532-5415.2008.02008.x","volume":"56","author":"MD Rothman","year":"2008","unstructured":"Rothman MD, Leo-Summers L, Gill TM (2008) Prognostic significance of potential frailty criteria. J Am Geriatr Soc 56(12):2211\u20132216. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02008.x","journal-title":"J Am Geriatr Soc"},{"key":"2603_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 1:323\u2013336. \n                    https:\/\/doi.org\/10.1100\/tsw.2001.58","journal-title":"ScientificWorldJournal"},{"key":"2603_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.03.007","volume":"31","author":"E Dent","year":"2016","unstructured":"Dent E, Kowal P, Hoogendijk EO (2016) Frailty measurement in research and clinical practice: a review. Eur J Intern Med 31:3\u201310. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2016.03.007","journal-title":"Eur J Intern Med"},{"key":"2603_CR46","unstructured":"European Medicines Agency (2018) Reflection paper on physical frailty: instruments for baseline characterisation of older populations in clinical trials. Available online at: \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/reflection-paper-physical-frailty-instruments-baseline-characterisation-older-populations-clinical_en.pdf\n                    \n                  . Accessed 5 Nov 2018"},{"issue":"4","key":"2603_CR47","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/ede.0000000000000833","volume":"29","author":"CC Cuthbertson","year":"2018","unstructured":"Cuthbertson CC, Kucharska-Newton A, Faurot KR, St\u00fcrmer T, Jonsson Funk M, Palta P, Windham BG, Thai S, Lund JL (2018) Controlling for frailty in pharmacoepidemiologic studies of older adults: validation of an existing Medicare claims-based algorithm. Epidemiology 29(4):556\u2013561. \n                    https:\/\/doi.org\/10.1097\/ede.0000000000000833","journal-title":"Epidemiology"},{"issue":"7","key":"2603_CR48","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J (2018) Measuring frailty in Medicare data: development and validation of a claims-based frailty index. J Gerontol A Biol Sci Med Sci 73(7):980\u2013987. \n                    https:\/\/doi.org\/10.1093\/gerona\/glx229","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"2603_CR49","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/mlr.0000000000000729","volume":"55","author":"JB Segal","year":"2017","unstructured":"Segal JB, Chang H-Y, Du Y, Walston JD, Carlson MC, Varadhan R (2017) Development of a claims-based frailty indicator anchored to a well-established frailty phenotype. Med Care 55(7):716\u2013722. \n                    https:\/\/doi.org\/10.1097\/mlr.0000000000000729","journal-title":"Med Care"},{"issue":"2","key":"2603_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/ageing\/afx001","volume":"47","author":"A Clegg","year":"2018","unstructured":"Clegg A, Bates C, Young J, Ryan R, Nichols L, Teale EA, Mohammed MA, Parry J, Marshall T (2018) Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing 47(2):319. \n                    https:\/\/doi.org\/10.1093\/ageing\/afx001","journal-title":"Age Ageing"},{"issue":"11","key":"2603_CR51","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.amjcard.2016.08.042","volume":"118","author":"A Pilotto","year":"2016","unstructured":"Pilotto A, Gallina P, Panza F, Copetti M, Cella A, Cruz-Jentoft A, Daragjati J, Ferrucci L, Maggi S, Mattace-Raso F, Paccalin M, Polidori MC, Topinkova E, Trifir\u00f2 G, Welmer AK, Strandberg T, Marchionni N; MPI_AGE Project Investigators (2016) Relation of statin use and mortality in community-dwelling frail older patients with coronary artery disease. Am J Cardiol 118(11):1624\u20131630. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.042","journal-title":"Am J Cardiol"},{"key":"2603_CR52","doi-asserted-by":"publisher","unstructured":"Martinez BK, Sood NA, Bunz TJ, Coleman CI (2018) Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation. J Am Heart Assoc 7(8). pii: e008643. \n                    https:\/\/doi.org\/10.1161\/jaha.118.008643","DOI":"10.1161\/jaha.118.008643"},{"issue":"5","key":"2603_CR53","doi-asserted-by":"publisher","first-page":"234.e21","DOI":"10.1016\/j.urolonc.2015.12.005","volume":"34","author":"JP Droz","year":"2016","unstructured":"Droz JP, Efstathiou E, Yildirim A, Cabrera P, Soo Kim C, Horchani A, Heidenreich A, Rinck-Junior JA, Hitier S, \u04e6zen H (2016) First-line treatment in senior adults with metastatic castration-resistant prostate cancer: a prospective international registry. Urol Oncol 34(5):234.e21\u2013234.e29. \n                    https:\/\/doi.org\/10.1016\/j.urolonc.2015.12.005","journal-title":"Urol Oncol"},{"issue":"5","key":"2603_CR54","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1532-5415.2012.03940.x","volume":"60","author":"SL Lakey","year":"2012","unstructured":"Lakey SL, LaCroix AZ, Gray SL, Borson S, Williams CD, Calhoun D, Goveas JS, Smoller JW, Ockene JK, Masaki KH, Coday M, Rosal MC, Woods NF (2012) Antidepressant use, depressive symptoms, and incident frailty in women aged 65 and older from the Women\u2019s Health Initiative Observational Study. J Am Geriatr Soc 60(5):854\u2013861. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03940.x","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"2603_CR55","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","unstructured":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227\u20132246. \n                    https:\/\/doi.org\/10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2603_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P (2015) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213\u2013218. \n                    https:\/\/doi.org\/10.1093\/ageing\/afu145","journal-title":"Age Ageing"},{"issue":"6","key":"2603_CR57","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ageing\/afu029","volume":"43","author":"M Tosato","year":"2014","unstructured":"Tosato M, Landi F, Martone AM, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G; Investigators of the CRIME Study (2014) Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing 43(6):767\u2013773. \n                    https:\/\/doi.org\/10.1093\/ageing\/afu029","journal-title":"Age Ageing"},{"issue":"8","key":"2603_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00228-007-0321-5","volume":"63","author":"F Landi","year":"2007","unstructured":"Landi F, Russo A, Liperoti R, Barillaro C, Danese P, Pahor M, Bernabei R, Onder G (2007) Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 63(8):791\u2013799. \n                    https:\/\/doi.org\/10.1007\/s00228-007-0321-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"2603_CR59","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1177\/1060028014548568","volume":"48","author":"A Poudel","year":"2014","unstructured":"Poudel A, Peel NM, Nissen L, Mitchell C, Gray LC, Hubbard RE (2014) Potentially inappropriate prescribing in older patients discharged from acute care hospitals to residential aged care facilities. Ann Pharmacother 48(11):1425\u20131433. \n                    https:\/\/doi.org\/10.1177\/1060028014548568","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2603_CR60","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11096-014-9940-y","volume":"36","author":"LD Jensen","year":"2014","unstructured":"Jensen LD, Andersen O, Hallin M, Petersen J (2014) Potentially inappropriate medication related to weakness in older acute medical patients. Int J Clin Pharm 36(3):570\u2013580. \n                    https:\/\/doi.org\/10.1007\/s11096-014-9940-y","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2603_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.amjmed.2003.10.031","volume":"116","author":"KE Schmader","year":"2004","unstructured":"Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, Francis SD, Branch LG, Lindblad CI, Artz M, Weinberger M, Feussner JR, Cohen HJ (2004) Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116(6):394\u2013401. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2003.10.031","journal-title":"Am J Med"},{"key":"2603_CR62","volume-title":"Geriatrics at your fingertips: 2017","author":"DB Reuben","year":"2017","unstructured":"Reuben DB, Herr KA, Pacala JT, Pollock BG, Potter JF, Semla TP (2017) Geriatrics at your fingertips: 2017, 19th edn. American Geriatrics Society, New York","edition":"19"},{"issue":"3","key":"2603_CR63","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.2042-7174.2011.00177.x","volume":"20","author":"BJ Basger","year":"2012","unstructured":"Basger BJ, Chen TF, Moles RJ (2012) Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract 20(3):172\u2013182. \n                    https:\/\/doi.org\/10.1111\/j.2042-7174.2011.00177.x","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"2603_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/02813430902992215","volume":"27","author":"S Rognstad","year":"2009","unstructured":"Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27(3):153\u2013159. \n                    https:\/\/doi.org\/10.1080\/02813430902992215","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"2603_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40801-016-0085-2","volume":"3","author":"B Wickop","year":"2016","unstructured":"Wickop B, H\u00e4rterich S, Sommer C, Daubmann A, Baehr M, Langebrake C (2016) Potentially inappropriate medication use in multimorbid elderly inpatients: differences between the FORTA, PRISCUS and STOPP ratings. Drugs 3(3):317\u2013325. \n                    https:\/\/doi.org\/10.1007\/s40801-016-0085-2","journal-title":"Drugs"},{"issue":"6","key":"2603_CR66","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00228-014-1667-0","volume":"70","author":"B Popovi\u0107","year":"2014","unstructured":"Popovi\u0107 B, Quadranti NR, Matanovi\u0107 SM, Lisica ID, Ljubotina A, Duliba DP, Vlahovi\u0107-Pal\u010devski V (2014) Potentially inappropriate prescribing in elderly outpatients in Croatia. Eur J Clin Pharmacol 70(6):737\u2013744. \n                    https:\/\/doi.org\/10.1007\/s00228-014-1667-0","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2603_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40266-012-0039-7","volume":"30","author":"DP O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan DP, O\u2019Mahony D, Parsons C, Hughes C, Murphy K, Patterson S, Byrne S (2013) A prevalence study of potentially inappropriate prescribing in Irish long-term care residents. Drugs Aging 30(1):39\u201349. \n                    https:\/\/doi.org\/10.1007\/s40266-012-0039-7","journal-title":"Drugs Aging"},{"issue":"9","key":"2603_CR68","doi-asserted-by":"publisher","first-page":"862.e1","DOI":"10.1016\/j.jamda.2016.06.011","volume":"17","author":"L Morin","year":"2016","unstructured":"Morin L, Laroche ML, Texier G, Johnell K (2016) Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc 17(9):862.e1\u2013862.e9. \n                    https:\/\/doi.org\/10.1016\/j.jamda.2016.06.011","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"2603_CR69","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","volume":"71","author":"E Tommelein","year":"2015","unstructured":"Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K (2015) Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 71(12):1415\u20131427. \n                    https:\/\/doi.org\/10.1007\/s00228-015-1954-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2603_CR70","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/jgs.14077","volume":"64","author":"M Jir\u00f3n","year":"2016","unstructured":"Jir\u00f3n M, Pate V, Hanson LC, Lund JL, Jonsson Funk M, St\u00fcrmer T (2016) Trends in prevalence and determinants of potentially inappropriate prescribing in the United States: 2007 to 2012. J Am Geriatr Soc 64(4):788\u2013797. \n                    https:\/\/doi.org\/10.1111\/jgs.14077","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"2603_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008656","volume":"5","author":"F Moriarty","year":"2015","unstructured":"Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T (2015) Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 5(9):e008656. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-008656","journal-title":"BMJ Open"},{"issue":"1","key":"2603_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jgs.13884","volume":"64","author":"JD Brown","year":"2016","unstructured":"Brown JD, Hutchison LC, Li C, Painter JT, Martin BC (2016) Predictive validity of the Beers and Screening Tool of Older Persons\u2019 potentially inappropriate Prescriptions (STOPP) criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. J Am Geriatr Soc 64(1):22\u201330. \n                    https:\/\/doi.org\/10.1111\/jgs.13884","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2603_CR73","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1177\/1060028014552821","volume":"48","author":"C Cahir","year":"2014","unstructured":"Cahir C, Moriarty F, Teljeur C, Fahey T, Bennett K (2014) Potentially inappropriate prescribing and vulnerability and hospitalization in older community-dwelling patients. Ann Pharmacother 48(12):1546\u20131554. \n                    https:\/\/doi.org\/10.1177\/1060028014552821","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2603_CR74","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/glw140","volume":"72","author":"E Wallace","year":"2017","unstructured":"Wallace E, McDowell R, Bennett K, Fahey T, Smith SM (2017) Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci 72(2):271\u2013277. \n                    https:\/\/doi.org\/10.1093\/gerona\/glw140","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"2603_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167586","volume":"11","author":"E Blanco-Reina","year":"2016","unstructured":"Blanco-Reina E, Garc\u00eda-Merino MR, Oca\u00f1a-Riola R, Aguilar-Cano L, Valdell\u00f3s J, Bellido-Est\u00e9vez I, Ariza-Zafra G (2016) Assessing potentially inappropriate prescribing in community-dwelling older patients using the updated version of STOPP-START criteria: a comparison of profiles and prevalences with respect to the original version. PLoS One 11(12):e0167586. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0167586","journal-title":"PLoS One"},{"issue":"11","key":"2603_CR76","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.293.11.1348","volume":"293","author":"D Fialov\u00e1","year":"2005","unstructured":"Fialov\u00e1 D, Topinkov\u00e1 E, Gambassi G, Finne-Soveri H, J\u00f3nsson PV, Carpenter I, Schroll M, Onder G, S\u00f8rbye LW, Wagner C, Reissigov\u00e1 J, Bernabei R; AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348\u20131358. \n                    https:\/\/doi.org\/10.1001\/jama.293.11.1348","journal-title":"JAMA"},{"issue":"22","key":"2603_CR77","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.286.22.2823","volume":"286","author":"C Zhan","year":"2001","unstructured":"Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS (2001) Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA 286(22):2823\u20132829","journal-title":"JAMA"},{"issue":"9","key":"2603_CR78","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1532-5415.2005.53523.x","volume":"53","author":"ER Hajjar","year":"2005","unstructured":"Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, Branch LC, Schmader KE (2005) Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 53(9):1518\u20131523. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53523.x","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2603_CR79","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s11096-012-9651-1","volume":"34","author":"LL Chen","year":"2012","unstructured":"Chen LL, Tangiisuran B, Shafie AA, Hassali MA (2012) Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. Int J Clin Pharm 34(4):596\u2013603. \n                    https:\/\/doi.org\/10.1007\/s11096-012-9651-1","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"2603_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082359","volume":"8","author":"F Napolitano","year":"2013","unstructured":"Napolitano F, Izzo MT, Di Giuseppe G, Angelillo IF; Collaborative Working Group (2013) Frequency of inappropriate medication prescription in hospitalized elderly patients in Italy. PLoS One 8(12):e82359. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0082359","journal-title":"PLoS One"},{"issue":"6","key":"2603_CR81","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80(6):1254\u20131268","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2603_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/ejhpharm-2015-000864","volume":"24","author":"I Scott","year":"2017","unstructured":"Scott I, Anderson K, Freeman C (2017) Review of structured guides for deprescribing. Eur J Hosp Pharm 24(1):51\u201357. \n                    https:\/\/doi.org\/10.1136\/ejhpharm-2015-000864","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"2603_CR83","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ageing\/afx005","volume":"46","author":"AH Lavan","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, O\u2019Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 46(4):600\u2013607. \n                    https:\/\/doi.org\/10.1093\/ageing\/afx005","journal-title":"Age Ageing"},{"key":"2603_CR84","doi-asserted-by":"publisher","unstructured":"Thompson W, Lundby C, Graabaek T, Nielsen DS, Ryg J, S\u00f8ndergaard J, Potteg\u00e5rd A (2018) Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review. J Am Geriatr Soc. \n                    https:\/\/doi.org\/10.1111\/jgs.15616","DOI":"10.1111\/jgs.15616"},{"issue":"3","key":"2603_CR85","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","volume":"82","author":"AT Page","year":"2016","unstructured":"Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD (2016) The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol 82(3):583\u2013623. \n                    https:\/\/doi.org\/10.1111\/bcp.12975","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2603_CR86","doi-asserted-by":"publisher","first-page":"e007488","DOI":"10.1136\/bmjopen-2014-007488","volume":"5","author":"I Abraha","year":"2015","unstructured":"Abraha I, Cruz-Jentoft A, Soiza RL, O\u2019Mahony D, Cherubini A (2015) Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: the SENATOR-ONTOP systematic review protocol. BMJ Open 5(1):e007488. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2014-007488","journal-title":"BMJ Open"},{"issue":"2","key":"2603_CR87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11909\/j.issn.1671-5411.2018.02.002","volume":"15","author":"B Jankowska-Pola\u0144ska","year":"2018","unstructured":"Jankowska-Pola\u0144ska B, Zam\u0119ta K, Uchmanowicz I, Szyma\u0144ska-Chabowska A, Morisky D, Mazur G (2018) Adherence to pharmacological and non-pharmacological treatment of frail hypertensive patients. J Geriatr Cardiol 15(2):153\u2013161. \n                    https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.02.002","journal-title":"J Geriatr Cardiol"},{"issue":"9838","key":"2603_CR88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0140-6736(12)61031-9","volume":"380","author":"IM Lee","year":"2012","unstructured":"Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet Physical Activity Series Working Group (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380(9838):219\u2013229. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(12)61031-9","journal-title":"Lancet"},{"issue":"5","key":"2603_CR89","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/japplphysiol.00362.2014","volume":"117","author":"DR Seals","year":"2014","unstructured":"Seals DR (2014) Edward F. Adolph distinguished lecture: the remarkable anti-aging effects of aerobic exercise on systemic arteries. J Appl Physiol (1985) 117(5):425\u2013439. \n                    https:\/\/doi.org\/10.1152\/japplphysiol.00362.2014","journal-title":"J Appl Physiol (1985)"},{"issue":"19","key":"2603_CR90","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301(19):2024\u20132035. \n                    https:\/\/doi.org\/10.1001\/jama.2009.681","journal-title":"JAMA"},{"issue":"2","key":"2603_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jama.2012.128367","volume":"309","author":"WE Boden","year":"2013","unstructured":"Boden WE, Franklin BA, Wenger NK (2013) Physical activity and structured exercise for patients with stable ischemic heart disease. JAMA 309(2):143\u2013144. \n                    https:\/\/doi.org\/10.1001\/jama.2012.128367","journal-title":"JAMA"},{"key":"2603_CR92","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/cia.S132496","volume":"12","author":"I Lozano-Montoya","year":"2017","unstructured":"Lozano-Montoya I, Correa-P\u00e9rez A, Abraha I, Soiza RL, Cherubini A, O\u2019Mahony D, Cruz-Jentoft AJ (2017) Nonpharmacological interventions to treat physical frailty and sarcopenia in older patients: a systematic overview\u2014the SENATOR Project ONTOP Series. Clin Interv Aging 12:721\u2013740. \n                    https:\/\/doi.org\/10.2147\/cia.S132496","journal-title":"Clin Interv Aging"},{"key":"2603_CR93","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Velilla N, Casas-Herrero A, Zambom-Ferraresi F, L\u00f3pez S\u00e1ez de Asteasu M, Lucia A, Galbete A, Garc\u00eda-Bazt\u00e1n A, Alonso-Renedo J, Gonz\u00e1lez-Glar\u00eda B, Gonzalo-L\u00e1zaro M, Apeztegu\u00eda Ir\u00e1izoz I, Guti\u00e9rrez-Valencia M, Rodr\u00edguez-Ma\u00f1as L, Izquierdo M (2018) Effect of exercise intervention on functional decline in very elderly patients during acute hospitalization: a randomized clinical trial. JAMA Intern Med. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2018.4869","DOI":"10.1001\/jamainternmed.2018.4869"},{"key":"2603_CR94","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12875-015-0284-z","volume":"16","author":"R Heseltine","year":"2015","unstructured":"Heseltine R, Skelton DA, Kendrick D, Morris RW, Griffin M, Haworth D, Masud T, Iliffe S (2015) \u201cKeeping Moving\u201d: factors associated with sedentary behaviour among older people recruited to an exercise promotion trial in general practice. BMC Fam Pract 16:67. \n                    https:\/\/doi.org\/10.1186\/s12875-015-0284-z","journal-title":"BMC Fam Pract"},{"issue":"6","key":"2603_CR95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12603-014-0029-z","volume":"18","author":"F Sganga","year":"2014","unstructured":"Sganga F, Vetrano DL, Volpato S, Cherubini A, Ruggiero C, Corsonello A, Fabbietti P, Lattanzio F, Bernabei R, Onder G (2014) Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study. J Nutr Health Aging 18(6):616\u2013621. \n                    https:\/\/doi.org\/10.1007\/s12603-014-0029-z","journal-title":"J Nutr Health Aging"},{"key":"2603_CR96","doi-asserted-by":"publisher","unstructured":"Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (2015) Exercise programs for people with dementia. Cochrane Database Syst Rev (4):CD006489. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006489.pub4","DOI":"10.1002\/14651858.CD006489.pub4"},{"key":"2603_CR97","doi-asserted-by":"publisher","unstructured":"Young J, Angevaren M, Rusted J, Tabet N (2015) Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev (4):CD005381. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005381.pub4","DOI":"10.1002\/14651858.CD005381.pub4"},{"issue":"8","key":"2603_CR98","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.mayocp.2016.04.024","volume":"91","author":"A Santos-Lozano","year":"2016","unstructured":"Santos-Lozano A, Pareja-Galeano H, Sanchis-Gomar F, Quind\u00f3s-Rubial M, Fiuza-Luces C, Cristi-Montero C, Emanuele E, Garatachea N, Lucia A (2016) Physical activity and Alzheimer disease: a protective association. Mayo Clin Proc 91(8):999\u20131020. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2016.04.024","journal-title":"Mayo Clin Proc"},{"key":"2603_CR99","doi-asserted-by":"publisher","first-page":"CD005465","DOI":"10.1002\/14651858.CD005465.pub4","volume":"9","author":"ID Cameron","year":"2018","unstructured":"Cameron ID, Dyer SM, Panagoda CE, Murray GR, Hill KD, Cumming RG, Kerse N (2018) Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 9:CD005465. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005465.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2603_CR100","doi-asserted-by":"publisher","unstructured":"Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev (9):CD007146. \n                    https:\/\/doi.org\/10.1002\/14651858.CD007146.pub3","DOI":"10.1002\/14651858.CD007146.pub3"},{"issue":"5","key":"2603_CR101","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1152\/physiol.00019.2013","volume":"28","author":"C Fiuza-Luces","year":"2013","unstructured":"Fiuza-Luces C, Garatachea N, Berger NA, Lucia A (2013) Exercise is the real polypill. Physiology (Bethesda) 28(5):330\u2013358. \n                    https:\/\/doi.org\/10.1152\/physiol.00019.2013","journal-title":"Physiology (Bethesda)"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2603-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:05:36Z","timestamp":1578078336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2603-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2603"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2603-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have been supported in participation at meetings of the EU COST Action IS1402 initiative \u201cAgeism - interprofessional, multidisciplinary perspectives\u201d (April 2015\u2013October 2018). Dr. Fialov\u00e1 has been supported as Chair of the FIP7 program of the EUROAGEISM H2020 project, no. 764632, Horizon 2020-MSCA-ITN (2017\u20132021), and by the scientific program PROGRESS Q42 at the Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Charles University, Czech Republic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}